ARA-290 Peptide is a premium-quality synthetic research peptide engineered to selectively activate the Innate Repair Receptor (IRR) while avoiding stimulation of erythropoiesis. Derived from the tissue-protective region of erythropoietin (EPO), ARA-290 has become an important research tool for scientists investigating inflammation, tissue regeneration, ischemic injury, peripheral nerve repair, and neuroprotective signaling pathways.

Manufactured to a purity of ≥98% as verified by HPLC and Mass Spectrometry, our Research Grade ARA-290 delivers exceptional consistency, stability, and reproducibility for laboratory applications. Each batch undergoes rigorous quality control testing to ensure dependable experimental performance.

Researchers commonly utilize ARA-290 in studies examining neuropathic pain, chronic inflammatory disorders, metabolic stress, ischemia-reperfusion injury, and small fiber neuropathy. Unlike recombinant erythropoietin, ARA-290 selectively targets the innate repair receptor without increasing red blood cell production, making it an attractive compound for investigating tissue-protective mechanisms independent of hematopoietic activity.

This product is intended strictly for laboratory research purposes only. It is not approved for human consumption, therapeutic use, veterinary use, or diagnostic applications.